The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience
|
---|---|
Published in |
Frontiers in Pharmacology, November 2020
|
DOI | 10.3389/fphar.2020.592543 |
Pubmed ID | |
Authors |
Aurélien Mary, Lucie Hénaut, Pierre Yves Macq, Louise Badoux, Arnaud Cappe, Thierry Porée, Myriam Eckes, Hervé Dupont, Michel Brazier |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 5% |
Russia | 1 | 5% |
United States | 1 | 5% |
Belgium | 1 | 5% |
Unknown | 15 | 79% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 89% |
Practitioners (doctors, other healthcare professionals) | 2 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 62 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 10 | 16% |
Student > Bachelor | 8 | 13% |
Researcher | 6 | 10% |
Student > Master | 5 | 8% |
Student > Doctoral Student | 3 | 5% |
Other | 7 | 11% |
Unknown | 23 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 26% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 10% |
Nursing and Health Professions | 5 | 8% |
Agricultural and Biological Sciences | 3 | 5% |
Environmental Science | 1 | 2% |
Other | 7 | 11% |
Unknown | 24 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2023.
All research outputs
#2,279,563
of 26,368,738 outputs
Outputs from Frontiers in Pharmacology
#978
of 20,252 outputs
Outputs of similar age
#60,359
of 534,135 outputs
Outputs of similar age from Frontiers in Pharmacology
#37
of 491 outputs
Altmetric has tracked 26,368,738 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,252 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 534,135 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 491 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.